ReviewCancers2022

Overall Survival Benefits of First-Line Treatments for Asian Patients with Advanced Epidermal Growth Factor Receptor-Mutated NSCLC Harboring Exon 19 Deletion: A Systematic Review and Network Meta-Analysis.

Sik-Kwan Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.